Semler Scientific

Semler Scientific, Inc. is a medical technology company based in San Jose, California, that develops, manufactures, and markets proprietary products aimed at assisting healthcare providers in evaluating and treating patients with chronic diseases. Its primary product, QuantaFlo, is a four-minute in-office blood flow test that helps healthcare professionals assess vascular conditions more efficiently. The company's offerings are utilized by a range of medical specialists, including cardiologists and internists, as well as healthcare insurance plans and integrated delivery networks. Founded in 2007, Semler Scientific has focused on creating tools that enable healthcare providers to capture full reimbursement potential for their services, thereby improving clinical effectiveness and operational efficiency in the healthcare sector.

Doug Murphy Chutorian

Interim CEO

2 past transactions

Monarch Medical Technologies

Debt Financing in 2022
Monarch Medical Technologies is a medical technology company that specializes in computer-based solutions for healthcare institutions, primarily focusing on glycemic management. The company has developed the EndoTool Glucose Management System, a software application designed to enhance inpatient glycemic control by replacing traditional manual insulin dosing methods with a more intuitive, predictive approach. This FDA-cleared system integrates seamlessly with major electronic medical record (EMR) systems, providing tailored management for both critical and non-critical care patients. In addition to the glucose management system, Monarch also offers EndoTool Analytics, which helps healthcare organizations identify and analyze performance trends related to glycemic control, enabling improved clinical outcomes. The company further supports its offerings with clinical consulting services, contributing to its mission of optimizing patient care in diverse healthcare settings. Monarch Medical Technologies is based in the United States.

Synaps Dx

Corporate Round in 2022
Synaps Dx is a privately held company focused on the research, development, and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.